Matches in SemOpenAlex for { <https://semopenalex.org/work/W2016019346> ?p ?o ?g. }
Showing items 1 to 79 of
79
with 100 items per page.
- W2016019346 endingPage "1139" @default.
- W2016019346 startingPage "1135" @default.
- W2016019346 abstract "The relative risk of diabetes among patients undergoing risperidone treatment was compared with that of patients receiving olanzapine.A cohort was formed of 33,946 patients with at least 1 prescription for either olanzapine (N = 19,153) or risperidone (N = 14,793) between January 1, 1997, and December 31, 1999, recorded in the Régie de l'Assurance Maladie du Québec database. Patients were excluded if clozapine was dispensed to them during the study period or if they were diagnosed with diabetes before beginning antipsychotic therapy. New diabetes diagnoses made after the first antipsychotic prescription during the period were tabulated until December 31, 1999; censoring occurred at this date or at the last service date, if there was no record of using services during the last 6 months of follow-up. Crude hazard ratio and proportional hazard analyses were carried out.319 patients developed diabetes on olanzapine treatment, and 217 developed diabetes on risperidone treatment; a crude hazard ratio of 1.08 (95% CI = 0.89 to 1.31, p =.43) was determined. When age, gender, and haloperidol use were controlled for using proportional hazard analysis, there was a 20% increased risk of diabetes with olanzapine relative to risperidone (95% CI = 0% to 43%, p =.05). Proportional hazard analyses adjusted for duration of olanzapine exposure indicated that the first 3 months of olanzapine treatment was associated with an increased risk of diabetes of 90% (95% CI = 40% to 157%, p <.0001), after adjusting for age, gender, and haloperidol use.Compared with risperidone, olanzapine was associated with an increased risk of developing diabetes. More studies are required to further investigate this association." @default.
- W2016019346 created "2016-06-24" @default.
- W2016019346 creator A5001923311 @default.
- W2016019346 creator A5017043744 @default.
- W2016019346 creator A5074020123 @default.
- W2016019346 creator A5072937936 @default.
- W2016019346 date "2002-12-15" @default.
- W2016019346 modified "2023-10-16" @default.
- W2016019346 title "The Risk of Diabetes During Olanzapine Use Compared With Risperidone Use" @default.
- W2016019346 doi "https://doi.org/10.4088/jcp.v63n1208" @default.
- W2016019346 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/12523873" @default.
- W2016019346 hasPublicationYear "2002" @default.
- W2016019346 type Work @default.
- W2016019346 sameAs 2016019346 @default.
- W2016019346 citedByCount "129" @default.
- W2016019346 countsByYear W20160193462013 @default.
- W2016019346 countsByYear W20160193462014 @default.
- W2016019346 countsByYear W20160193462015 @default.
- W2016019346 countsByYear W20160193462016 @default.
- W2016019346 countsByYear W20160193462017 @default.
- W2016019346 countsByYear W20160193462018 @default.
- W2016019346 countsByYear W20160193462019 @default.
- W2016019346 countsByYear W20160193462020 @default.
- W2016019346 countsByYear W20160193462021 @default.
- W2016019346 crossrefType "journal-article" @default.
- W2016019346 hasAuthorship W2016019346A5001923311 @default.
- W2016019346 hasAuthorship W2016019346A5017043744 @default.
- W2016019346 hasAuthorship W2016019346A5072937936 @default.
- W2016019346 hasAuthorship W2016019346A5074020123 @default.
- W2016019346 hasConcept C118552586 @default.
- W2016019346 hasConcept C126322002 @default.
- W2016019346 hasConcept C134018914 @default.
- W2016019346 hasConcept C207103383 @default.
- W2016019346 hasConcept C2776412080 @default.
- W2016019346 hasConcept C2776619155 @default.
- W2016019346 hasConcept C2780057945 @default.
- W2016019346 hasConcept C2780494398 @default.
- W2016019346 hasConcept C2780864610 @default.
- W2016019346 hasConcept C2780948584 @default.
- W2016019346 hasConcept C44249647 @default.
- W2016019346 hasConcept C513476851 @default.
- W2016019346 hasConcept C555293320 @default.
- W2016019346 hasConcept C71924100 @default.
- W2016019346 hasConceptScore W2016019346C118552586 @default.
- W2016019346 hasConceptScore W2016019346C126322002 @default.
- W2016019346 hasConceptScore W2016019346C134018914 @default.
- W2016019346 hasConceptScore W2016019346C207103383 @default.
- W2016019346 hasConceptScore W2016019346C2776412080 @default.
- W2016019346 hasConceptScore W2016019346C2776619155 @default.
- W2016019346 hasConceptScore W2016019346C2780057945 @default.
- W2016019346 hasConceptScore W2016019346C2780494398 @default.
- W2016019346 hasConceptScore W2016019346C2780864610 @default.
- W2016019346 hasConceptScore W2016019346C2780948584 @default.
- W2016019346 hasConceptScore W2016019346C44249647 @default.
- W2016019346 hasConceptScore W2016019346C513476851 @default.
- W2016019346 hasConceptScore W2016019346C555293320 @default.
- W2016019346 hasConceptScore W2016019346C71924100 @default.
- W2016019346 hasIssue "12" @default.
- W2016019346 hasLocation W20160193461 @default.
- W2016019346 hasLocation W20160193462 @default.
- W2016019346 hasOpenAccess W2016019346 @default.
- W2016019346 hasPrimaryLocation W20160193461 @default.
- W2016019346 hasRelatedWork W1969458165 @default.
- W2016019346 hasRelatedWork W1975087639 @default.
- W2016019346 hasRelatedWork W1979819977 @default.
- W2016019346 hasRelatedWork W1990165054 @default.
- W2016019346 hasRelatedWork W2027123980 @default.
- W2016019346 hasRelatedWork W2050715650 @default.
- W2016019346 hasRelatedWork W2105267541 @default.
- W2016019346 hasRelatedWork W2149805979 @default.
- W2016019346 hasRelatedWork W2316286611 @default.
- W2016019346 hasRelatedWork W3109919181 @default.
- W2016019346 hasVolume "63" @default.
- W2016019346 isParatext "false" @default.
- W2016019346 isRetracted "false" @default.
- W2016019346 magId "2016019346" @default.
- W2016019346 workType "article" @default.